Ş. ŞENTÜRK Et Al. , "SOCS2 leads to EGFR TKi resistance in lung cancer by activating IL 6 mediated signaling," Mechanisms & Models of Cancer Meeting, CSHL , 2012
ŞENTÜRK, Ş. Et Al. 2012. SOCS2 leads to EGFR TKi resistance in lung cancer by activating IL 6 mediated signaling. Mechanisms & Models of Cancer Meeting, CSHL .
ŞENTÜRK, Ş., TAŞ, İ., YAO, Z., FENOGLİO, S., & SORDELLA, R., (2012). SOCS2 leads to EGFR TKi resistance in lung cancer by activating IL 6 mediated signaling . Mechanisms & Models of Cancer Meeting, CSHL
ŞENTÜRK, ŞERİF Et Al. "SOCS2 leads to EGFR TKi resistance in lung cancer by activating IL 6 mediated signaling," Mechanisms & Models of Cancer Meeting, CSHL, 2012
ŞENTÜRK, ŞERİF Et Al. "SOCS2 leads to EGFR TKi resistance in lung cancer by activating IL 6 mediated signaling." Mechanisms & Models of Cancer Meeting, CSHL , 2012
ŞENTÜRK, Ş. Et Al. (2012) . "SOCS2 leads to EGFR TKi resistance in lung cancer by activating IL 6 mediated signaling." Mechanisms & Models of Cancer Meeting, CSHL .
@conferencepaper{conferencepaper, author={ŞERİF ŞENTÜRK Et Al. }, title={SOCS2 leads to EGFR TKi resistance in lung cancer by activating IL 6 mediated signaling}, congress name={Mechanisms & Models of Cancer Meeting, CSHL}, city={}, country={}, year={2012}}